Status: Recruiting
Discontinuation of Antithrombotic Treatment Following Patent Foramen Ovale Closure in Young Patients With Cryptogenic Stroke
To determine the safety of antithrombotic treatment discontinuation 12 months following successful transcatheter PFO closure.
Participants needed: 100
Trial details
Age: 18-60Biological sex: AllType: InterventionalSponsor: Josep Rodes-CabauUpdated: Mar 24, 2026Locations: 1
Eligibility criteria
Successful transcatheter PFO closure with any approved device [+1]
RoPE score <6 [+8]